Clinical Trial Detail

NCT ID NCT03526185
Title A Pilot Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Yale University
Indications

melanoma

Therapies

tumor infiltrating lymphocytes

Age Groups: senior adult

No variant requirements are available.